RE:RE:RE:RE:RE:RE:Q1 resultsHaving re-watched the presentation, I'm inclined to agree with you. Here's the relevant bit:
"There is more news coming on the FeraMAX brand as we roll through, and not just this year but over the next couple of years. We've been working on a few things over the last couple years on this brand, so stay tuned for some news on that topic."
This does seem to be a little different than their usual commentary about new drug deals possibly being announced and new geographic areas for FeraMAX.
Good find!
overnout wrote: Thanks for the feedback. I have been invested here for quite some time but not made any comments. I have appreciated your comments and those of Iscfa on Biosyent.
The thing that tweeked my interest with Rene's comment was that we have known about their domestic sales of FeraMax and their international licensing/sales ups and downs, but this comment seemed to indicate a new market. Maybe I'm reading too much into it, but it sounded different.
overnout